{
  "docId": "019de071-9145-7451-a6ec-7c649022aff2",
  "docSlug": "b4b3dce82987f00e376d7c3ca528aedf",
  "documentTitle": "Alkermes | Results Presentation Deck | 11 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 11,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 11,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-9145-7451-a6ec-7c649022aff2/8",
  "deckHref": "/decks/019de071-9145-7451-a6ec-7c649022aff2",
  "deckJsonHref": "/decks/019de071-9145-7451-a6ec-7c649022aff2.json",
  "deckAnchorHref": "/decks/019de071-9145-7451-a6ec-7c649022aff2#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "ARISTADA Quarterly TRx MOT",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71a4bfbd-ff1e-4f52-a499-c23a61a18752",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.68,
        "y": 0.25
      },
      "kind": "list",
      "text": "Q3’21 year-over-year growth of 15% on TRx months of therapy (MOT) basis; Outpaced overall atypical long-acting injectable (LAI) market Q3’21 year-over-year growth of 6%; Market share: TRx MOT: 9.8% of atypical LAI market prescriptions in Q3’21",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2df3f3a3-92e5-4b80-9be3-a3eca25ebdac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Source: IQVIA NPA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "388be22c-fc41-4a8a-abf7-8bd82b487e22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "ARISTADA®: Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e7ad658-e3cc-4e4c-b5a0-9b57dd4d3b8c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "8df9212c-2739-48e3-a904-a8bac6fff626",
      "evidence": "The deck presents a logical chain of financial results and business performance",
      "position": 0,
      "objective": "To demonstrate strong financial and operational performance",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}